FDA continues to enforce through its new 21 CFR Part 11 inspection

  • 150.00 Dollar US$
  • Published date: July 11, 2018
    • Fremont, California, United States

Overview:
The webinar will have the answers. In addition, using industry proven case studies on how to avoid 483 inspectional observations and warning letters attendees will learn how to prepare their organization for trouble-free Part 11 related inspections.

Areas Covered in the Session:
FDA's current inspection and enforcement practices
FDA's new interpretation: learning from FDA inspection reports
Strategy for cost-effective implementation of Part 11: A six step plan
Justification and documentation for the FDA and your management

Who Will Benefit:
QC Managers
QA Managers and Personnel
IT Administrators
Analysts
Regulatory Affairs
Training Departments
Documentation Department
Consultants

Speaker Profile:
Ludwig Huber Ph.D., is the director and editor of Labcompliance the global online resource for validation and compliance. He is the author of the books "Validation and Qualification in Analytical Laboratories" and "Validation of Computerized Analytical and Networked Systems, Informa Healthcare". He has given more than 300 presentations mainly on GLP/GMP, 21 CFR Part 11 and Validation around the world.

Event Fee: One Dial-in One Attendee Price: US$150.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com

Result 0 votes
Compliance4All
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Zfp57 peptide

    Zfp57 peptide

    Bioinformatics - Data Analysis Shirley (New York) February 22, 2019 10.00 Dollar US$

    Zfp57 is a putative transcription factor that is a marker of mouse embryonic stem cell pluripotency, the expression of which decreases in the absence of LIF. https://www.creative-diagnostics.com/Zfp57-peptide-178403-427.htm

  • HIPAA 2019 - Staying Competitive and Complying with HIPAA

    HIPAA 2019 - Staying Competitive and Complying with HIPAA

    Bioinformatics - Data Analysis Fremont (California) January 21, 2019 545.00 Dollar US$

    This seminar will demonstrate how Covered Entities and Business Associates can comply calmly, confidently and completely with the HIPAA Rules. The secret is - HIPAA Rules are easy and routine to follow - when you know the steps. Paul Hales will captu...

  • Lead Discovery

    Lead Discovery

    Bioinformatics - Data Analysis Shirley (New York) January 10, 2019 Check with publisher

    Pharmaceutical development is an extreme complex process, involves discovery of innovative active ingredients and launch of a finished product, which always take more than ten years and enormous cost. The discovery of lead compounds are the initial r...